• Pharma
  • January 2, 2025
  • 147 views
Kwality Pharma gains on securing RCGM approval for Erythropoietin

Kwality Pharmaceuticals rose 3.19% to Rs 895 after the company secured approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for the recombinant Erythropoietin product,…